Study of Pharmacodynamic Equivalence of Enoxaparin Rovi to Clexane®, in Healthy Volunteers

计划入组 46 人 · 首次发布于 2017 年 12 月 6 日

Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study

计划入组 761 人 · 首次发布于 2021 年 3 月 23 日

Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING PUMA)

计划入组 500 人 · 首次发布于 2024 年 5 月 21 日

Enoxaparin sodium biosimilar (Rovi)

O-GlcNAcase inhibitors (Johnson & Johnson/Villapharma Research/Universitat Rovira I Virgili)

insulin

LABORATORIOS FARMACEUTICOS ROVI SA

Spain

ROVI Pharma Industrial Services S.A.

Spain

ROVI PHARMA INDUSTRIAL SERVICES SA.

Spain

ROVI Rebrands as ROIS, Expands U.S. Operations with $100M Phoenix Manufacturing Facility Acquisition

Moderna Begins Phase 3 COVE Study for COVID-19 mRNA Vaccine

Rovia Clinical Research Expands Network with New Mississippi Site Partnership